Bridgeway Capital Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.85 - $6.04 $406,429 - $506,152	-83,800 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.29 - $6.05 $89,232 - $125,840	20,800 Added 33.02%	83,800 $482,000
Q1 2021 May 17, 2021	SELL	$3.45 - $4.69 $91,425 - $124,285	-26,500 Reduced 29.61%	63,000 $290,000
Q4 2020 Feb 16, 2021	SELL	$2.97 - $3.83 $44,253 - $57,067	-14,900 Reduced 14.27%	89,500 $299,000
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $187,110 - $320,040	63,000 Added 152.17%	104,400 $310,000

Q1 2020 May 15, 2020	BUY	$2.61 - $5.21 $108,054 - $215,694	41,400 New	41,400 $159,000

277

95.7M

40.6K

67.2K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $1.59B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.